CLINICAL_TRIALS
trial_result
· 2017-02-23
Clinical Trial Update: D2212C00002 J-Phase II Study [Phase 2]
Summary
AstraZeneca's Phase II J-Phase study D2212C00002 for idiopathic pulmonary fibrosis has completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2017-02-23